NCT03811041

Brief Summary

Depression is difficult to identify, prevent and treat in adolescents because of complex and stigmatized multiform symptoms and pathways of care. In children the existence of a parental depression is a significant and recognized risk factor for the development of a depression. It is regularly reported that 30% of adolescents of depressed parents have depression themselves. General Practitioners (GP) have significant access to the depression of adults, potentially parents of teenagers. In fact, 20% of patients in the regular active file of one GP have depression. The primary health care system could provide indirect but voluminous and unprecedented access to the identification of adolescent depression at an early stage from the encounter of depressed parents. The difficulties of articulation between primary care (PC) and mental health devices are demonstrated. They disrupt the care pathways of adolescents detected in PC, prevention, and may even disturb early detection of depression. An organized joint between the PC and a specialized mental health service for adolescents ("Maison Des Adolescents" MDA) could promote the process of screening and preventing depression of adolescents of depressed parents encountered in PC. In addition, if the effects of parental depression on adolescents are established, they remain complex and interactive. They vary by age and sex of the child but also the sex of the parent. A concomitant study of adolescent and parent depression will provide data to analyze the prevalence of depressed parent adolescent depression and to define risk or protection factors. AdoDesP study is a cluster randomised trial (randomisation of the GPs) which compare a group of adolescent with PC articulated with mental health service (MDA) and an other group without articulation (routine cares). A third group of depressed adolescents will be constituted to analyse parental depression of depressed adolescents.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Enrollment
80

participants targeted

Target at P25-P50 for not_applicable depression

Timeline
Completed

Started Mar 2019

Geographic Reach
1 country

12 active sites

Status
terminated

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

First Submitted

Initial submission to the registry

January 15, 2019

Completed
7 days until next milestone

First Posted

Study publicly available on registry

January 22, 2019

Completed
2 months until next milestone

Study Start

First participant enrolled

March 28, 2019

Completed
2 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

March 11, 2021

Completed
Same day until next milestone

Study Completion

Last participant's last visit for all outcomes

March 11, 2021

Completed
Last Updated

April 11, 2022

Status Verified

April 1, 2022

Enrollment Period

2 years

First QC Date

January 15, 2019

Last Update Submit

April 4, 2022

Conditions

Outcome Measures

Primary Outcomes (1)

  • Changes in adolescents' depression intensity

    The depression intensity will be evaluated by Adolescent Depression Rating Scale (ADRS) at Day 0 and Month 12. The investigators will compare its evolution between group 1 (PC articulated with MDA) and 2 (Routine cares). Adolescent depression rating scale (ADRS) assesses depression in adolescents in 10 items. The items measure insomnia, anxiety, sadness and fatigability. If ADRS score is less than 4 : low risk of depression, between 4 and 8 : moderate risk of depression and more than 8 : significant risk of depression.

    Day 0 and Month12

Secondary Outcomes (5)

  • Diagnosis of depression rate

    Day 0

  • Changes in adolescents' quality of live

    Day 0, Month6 and Month12

  • Prevalence of adolescent depression with depressed parent

    Day 0

  • Prevalence of parental depression with depressed adolescent

    Day 0

  • Risk and protection factors

    Day 0

Study Arms (3)

PC articulated with MDA

EXPERIMENTAL

Depressed parent encountered in PC for confirmation of depression with Hopkins Symptom Checklist-25 (HSCL25) scale. If confirmed, the adolescent will also be encountered by the GP for a screening test of depression (Adolescent Depression Rating Scale - ADRS). If negative, the patient will go out of the study. If positive, 2 others tests will be performed to study the intensity of the depression (Child depressionInventory - CDI) and the quality of life (Pediatric Quality of Life InventoryTM).Finally, the patient will be oriented to the MDA of Brest and will meet again the GP at 6 and 12 month to answers the same tests.

Other: MDA

Routine cares

ACTIVE COMPARATOR

Depressed parent encountered in PC for confirmation of depression with Hopkins Symptom Checklist-25 (HSCL25) scale. If confirmed, the adolescent will also be encountered by the GP for a screening test of depression (Adolescent Depression Rating Scale - ADRS). If negative, the patient will go out of the study. If positive, 2 others tests will be performed to study the intensity of the depression (Child depressionInventory - CDI) and the quality of life (Pediatric Quality of Life InventoryTM). Finally, the patient will be oriented to the routine cares and will meet again the GP at 6 and 12 month to answers the same tests.

Other: Routine Cares

Parental depression

EXPERIMENTAL

Parental depression will be studied. Depressed adolescent encountered in MDA of Marseille for confirmation of depression with 3 tests : ADRS, CDI and PedsQL. If positive, the parent will come to the MDA for a screening test of depression (HSCL25). Parents and adolescent are seen only once.

Other: Parental depression

Interventions

MDAOTHER

Depressed adolescents of depressed parents will be oriented to the MDA of Brest for depression cares.

PC articulated with MDA

Depressed adolescents of depressed parents will be oriented to routine cares for depression cares.

Routine cares

Parents of depressed adolescents will be met for a screening test of depression.

Parental depression

Eligibility Criteria

Age11 Years+
Sexall
Healthy VolunteersNo
Age GroupsChild (0-17), Adult (18-64), Older Adult (65+)

You may qualify if:

  • Parents of groups 1 and 2 :
  • Major patient consulting his GP
  • Depressed patient
  • Parent of adolescent aged between 11 and 18 years old
  • Adolescents of groups 1 and 2 :
  • Aged more than 11 and less than 18 years old
  • Parent included in the study
  • Parents of group 3 :
  • Parent of depressed adolescent under care at the MDA of Marseille, included in the study and whose depression is confirmed by HSCL25 scale
  • Adolescents of group 3 :
  • Aged more than 11 and less than 18 years old
  • Depressed patient
  • Under care at the MDA of Marseille since less than 1 month

You may not qualify if:

  • Parents of groups 1, 2 and 3 :
  • Minor patient
  • Enable to give his consent
  • Patient with guardianship or curatorship
  • Non consenting patient
  • Pregnant or nursing mother
  • Adolescents of groups 1 and 2 :
  • Aged \< 11 or ≥18
  • Parent whose depression isn't confirmed by HSCL25 scale
  • Non consenting adolescent
  • Pregnant or nursing mother
  • Adolescent of group 3 :
  • Aged \< 11 or ≥18
  • Non depressed adolescent
  • Non consenting patient
  • +1 more criteria

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (12)

Dr Phan

Brest, 29200, France

Location

Dr Volant-Le-Berre

Brest, 29200, France

Location

Dr Wauters

Brest, 29200, France

Location

Dr AUGUSTIN

Guilers, 29802, France

Location

Dr Le Grignou

Guissény, 29880, France

Location

Dr Ac'h

Landerneau, 29800, France

Location

Dr PITMAN

Landivisiau, 29400, France

Location

Dr CHIRON

Le Relecq-Kerhuon, 29480, France

Location

Dr CONNAN

Le Relecq-Kerhuon, 29480, France

Location

Dr Cazuguel

Locmaria-Plouzané, 29280, France

Location

Dr Coat-Gourio

Plougastel-Daoulas, 29470, France

Location

Dr NABBE

Plounéour-Trez, 29890, France

Location

MeSH Terms

Conditions

Depression

Condition Hierarchy (Ancestors)

Behavioral SymptomsBehavior

Study Design

Study Type
interventional
Phase
not applicable
Allocation
RANDOMIZED
Masking
NONE
Purpose
DIAGNOSTIC
Intervention Model
PARALLEL
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

January 15, 2019

First Posted

January 22, 2019

Study Start

March 28, 2019

Primary Completion

March 11, 2021

Study Completion

March 11, 2021

Last Updated

April 11, 2022

Record last verified: 2022-04

Data Sharing

IPD Sharing
Will share

All collected data that underlie results in a publication

Shared Documents
STUDY PROTOCOL
Time Frame
Data will be available beginning 3 years and ending fifteen years following the final study report completion
Access Criteria
Data access requests will be reviewed by the internal committee of Brest UH. Requestors will be required to sign and complete a data access agreement

Locations